Activist 13D/13G Filings - Fairmount Funds Management LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, Next
Reported
DateTime
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportFiling
2024-06-13
06:06 am
Purchase
13DCogent Biosciences Inc.
COGT
Fairmount Funds Management LLC11,330,141
9.9%
1,343,585increase
(+13.45%)
View
2024-04-25
4:40 pm
Purchase
13DSPYRE THERAPEUTICS, INC
SYRE
Fairmount Funds Management LLC4,508,579
11.17%
3,672,120increase
(+439.01%)
View
2024-04-01
6:38 pm
Unchanged
13DViridian Therapeutics Inc.
VRDN
Fairmount Funds Management LLC13,956,685
18.64%
0
(Unchanged)
View
2024-04-01
6:34 pm
Sale
13DDIANTHUS THERAPEUTICS INC
DNTH
Fairmount Funds Management LLC2,957,385
9.99%
-3,362decrease
(-0.11%)
View
2024-04-01
6:30 pm
Sale
13DCogent Biosciences Inc.
COGT
Fairmount Funds Management LLC9,986,556
9.9%
-31,519decrease
(-0.31%)
View
2024-04-01
5:42 pm
Sale
13DApogee Therapeutics Inc.
APGE
Fairmount Funds Management LLC4,762,558
9.99%
-640,495decrease
(-11.85%)
View
2024-03-27
4:37 pm
Sale
13DCogent Biosciences Inc.
COGT
Fairmount Funds Management LLC10,018,075
9.9%
-13,061,066decrease
(-56.59%)
View
2024-02-16
6:55 pm
Purchase
13DCogent Biosciences Inc.
COGT
Fairmount Funds Management LLC23,079,141
18.89%
3,116,577increase
(+15.61%)
View
2024-02-14
3:49 pm
Sale
13GNuvalent Inc.
NUVL
Fairmount Funds Management LLC1,924,626
3.4%
-864,355decrease
(-30.99%)
View
2024-02-14
3:48 pm
Sale
13GTrevi Therapeutics Inc.
TRVI
Fairmount Funds Management LLC0
0%
-6,018,465decrease
(Position Closed)
View
2024-02-14
3:48 pm
Purchase
13GAstria Therapeutics Inc.
ATXS
Fairmount Funds Management LLC3,633,965
9.9%
1,732,568increase
(+91.12%)
View
2024-02-14
3:47 pm
Purchase
13GTerns Pharmaceuticals Inc.
TERN
Fairmount Funds Management LLC6,632,015
9.9%
1,362,728increase
(+25.86%)
View
2024-02-14
3:46 pm
Purchase
13GAxsome Therapeutics Inc.
AXSM
Fairmount Funds Management LLC2,360,077
4.9%
15,097increase
(+0.64%)
View
2024-02-14
3:46 pm
Purchase
13GKiniksa Pharmaceuticals Ltd.
KNSA
Fairmount Funds Management LLC2,883,221
8.1%
740,169increase
(+34.54%)
View
2024-02-14
3:45 pm
Sale
13GAnnexon Inc.
ANNX
Fairmount Funds Management LLC322,893
0.4%
-3,358,563decrease
(-91.23%)
View
2024-02-14
3:45 pm
Purchase
13GEnliven Therapeutics Inc.
ELVN
Fairmount Funds Management LLC2,131,369
5.2%
6,744increase
(+0.32%)
View
2024-01-31
4:30 pm
Purchase
13DApogee Therapeutics Inc.
APGE
Fairmount Funds Management LLC5,403,053
9.99%
1,496,851increase
(+38.32%)
View
2024-01-24
5:26 pm
Purchase
13DDIANTHUS THERAPEUTICS INC
DNTH
Fairmount Funds Management LLC2,960,747
9.9%
1,086,914increase
(+58.00%)
View
2024-01-24
5:12 pm
Purchase
13DViridian Therapeutics Inc.
VRDN
Fairmount Funds Management LLC13,956,685
19.43%
1,192,292increase
(+9.34%)
View
2023-12-29
5:00 pm
Sale
13DSPYRE THERAPEUTICS, INC
SYRE
Fairmount Funds Management LLC836,459
2.32%
-2,977,442decrease
(-78.07%)
View
Goto 0, 1, 2, Next